RANKINGS

POPULAR STOCKS

Acer Medical Inc.

Taipei Exchange:6857.TWO

Location

Taiwan

Market Cap

USD 62.20 M

Share Price

USD 4.09

Avg Daily Volume

3,093

Change (1 day)

0.17%

Change (1 year)

-20.56%

Change (YTD)

-5.68%

Acer Medical Inc. Revenue for the year ending December 31, 2024: USD 1.53 M

Acer Medical Inc. Revenue is USD 1.53 M for the year ending December 31, 2024, a 70.84% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Acer Medical Inc. Revenue for the year ending December 31, 2023 was USD 894.09 K, a 109.87% change year over year.
  • Acer Medical Inc. Revenue for the year ending December 31, 2022 was USD 426.03 K, a 22.67% change year over year.
  • Acer Medical Inc. Revenue for the year ending December 31, 2021 was USD 347.28 K, a 863.35% change year over year.
  • Acer Medical Inc. Revenue for the year ending December 31, 2020 was USD 36.05 K.
Key data
Date Revenue Revenue Gross Profit Operating Income
Market news
Taipei Exchange: 6857.TWO

Acer Medical Inc.

CEO Mr. Yin Xiong Xu
IPO Date March 4, 2022
Location Taiwan
Headquarters No. 88, Section 1, Xintai 5th Road
Employees 22
Sector 🏥 Health Care
Industries
Artificial Intelligence (AI)
📊 Big Data
🔬 Clinical Trials
🏥 Hospitals & Clinics
💻 Telehealth
Description

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.

StockViz Staff

June 16, 2025

Any question? Send us an email